|
Ong CA, Shapiro J, Nason KS, Davison JM, Liu X, Ross-Innes C, O'Donova... |
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma |
|
J Clin Oncol. |
|
Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kap... |
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer |
|
Hum Mol Genet. |
|
Griffiths DS, Li J, Dawson MA, Trotter MW, Cheng YH, Smith AM, Mansfield W,... |
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. |
|
Nat Cell Biol. |
|
Wilson NK, Foster SD, Wang X, Knezevic K, Schütte J, Kaimakis P, Chilarska... |
Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators |
|
Cell Stem Cell |
|
Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, L... |
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. |
|
Nature |
|
Watts, C., et al. |
Establishing the efficacy of Gliadel wafers: progress towards a Phase III trial |
|
Acta neurochirurgica |
|
Yuan Y, Failmezger H, Rueda OM, Ali HR, Graf S, Chin S-F, Schwarz RF, Curti... |
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling |
|
Science Translational Medicine |
|
Phillips, K. A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C.,... |
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers |
|
J Clin Oncol |
|
1.1 Walter FM, Morris HC, Humphrys E, Hall PN, Kinmonth A, Prevost A, Wilso... |
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. |
|
BMJ |
|
R. Gilley;K. Balmanno;C. L. Cope;S. J. Cook |
Adaptation to chronic mTOR inhibition in cancer and in aging |
|
Biochem Soc Trans |
